baber/WOPTO huggingface dataset:
Patent NZ-541650-A (NZ)
Title: System and method for facilitating responsible behaviour
Inventor: FLANAGAN JOHN THOMAS
IPC: G07F17/32
Filed: 2004-08-27
Abstract: A system (2) for facilitating responsible behaviour by an entity comprises: an identification means (32) for identifying the entity, a facility (4) for verifying the identification means and facilitating pursuit of the behaviour, a storage means (18) coupled to be in communication with the facility (4) for storing information related to the pursuit of the behaviour by the entity where the information is based on monitoring actual pursuit of the behaviour by the entity and a modeller module (24) couple to be in communication with the storage means for generating a profile of the entity based on the stored information related to the pursuit of the behaviour by the entity and comparing the profile to a behaviour model to determine a category of behaviour of the entity.
Patent NZ-543540-A (NZ)
Title: A removable cartridge assembly for a waterless urinal
Inventor: CUMMINGS STEPHEN JOHN
Filed: 2005-11-11
Abstract: A removable cartridge assembly (16) for a waterless urinal (10). The cartridge assembly comprises a cup (42) and a cap (46). The cup is adapted to receive a scent block (44) therein. The cap is adapted to releasably engage the cup. When the cap is engaged with the cup, the scent block is retained in the cup. When the cap is disengaged from the cup, the scent block is removable from within the cup, and thus from the cartridge assembly.
Patent NZ-551034-A (NZ)
Title: Head rail for a roman blind
Inventor: HEALEY MARTIN JAMES
Filed: 2006-11-02
Abstract: A head rail 6 for a conventional roman blind 1 is adapted on either its top side 6b or back side 6c to receive attachment means for securing the top of the roman blind thereto. The head rail 6 also includes a chain drive 7 adapted to be coupled with the body of the roman blind 1, such that in use the head rail 6 supports the weight of the roman blind 1and the chain drive 7 adjusts its length. Also disclosed is a bracket 3 adapted to support such a head rail, including a backing plate adapted to secure to a vertical surface (not shown) and a lower support adapted to support the head rail 6.
Patent NZ-551166-A (NZ)
Title: Controlled-release formulations containing vardenafil
Inventor: ZULEGER SUSANNE
IPC: A61K31/522
Filed: 2005-04-29
Abstract: Disclosed is a pharmaceutical dosage form with controlled release of active ingredient, which comprises the PDE 5 inhibitor vardenafil, or pharmaceutically acceptable salts, hydrates or solvates thereof, which has an average release rate of between 80% in 2 hours and 80% in 24 hours as tested by the method described in the specification. Also disclosed if the use of the above dosage form for treating erectile dysfunction or a disease which treatable by increasing the cGMP level.
Patent NZ-552953-A (NZ)
Title: Medical skin applicator apparatus with an internal fluid container, a penetrating member and actuated by an externally protruding member
Inventor: CABLE FRANK
IPC: A61M5/00
Filed: 2005-08-08
Abstract: A medical skin applicator apparatus comprises an outer housing 534 defining a longitudinal axis, a fluid housing 506 having a fluid chamber for storing a medical agent, a manually engagable member 530 connected to the fluid housing 506 and extending beyond the outer housing 534, and an applicator 504 coupled to the housing 534. The manually engagable member can be depressed to cause longitudinal movement of the fluid housing 506 to the actuated position. The fluid housing 506 has a cap 508 with a penetrable wall to permit access to the fluid chamber and release of the medical agent. The applicator 504 includes an applicator frame and an applicator surface for applying the medical agent to a patient. The applicator frame has an internal penetrating member 558 adapted to penetrate the penetrable wall of the fluid housing cap upon achieving a predetermined coupled relation of the fluid housing 506 and the applicator 504, to thereby permit the medical agent to be dispensed from the fluid chamber and applied to the patient with the applicator surface.
Patent NZ-555668-A (NZ)
Title: A method of and an apparatus for producing and regulating electrical power
Inventor: HENRIKSEN NIELS
IPC: F01K13/00
Filed: 2005-10-03
Abstract: A method of producing electrical power for delivery on an electrical power supply grid is disclosed. The method includes: providing at least one power plant capable of generating electrical power; providing a fuel producing plant capable of generating carbon and/or nitrogen based fuels using generated electrical power from the power plant and a combination of two or more materials selected from the group consisting of carbon dioxide, hydrogen, carbonaceous gasses, carbonaceous liquids, and nitrogen; determining a need for electrical power on the electrical power supply grid and delivering the needed electrical power to the electrical power grid from electrical power generated by the power plant; and delivering any excess generated electrical power from the power plant to the fuel producing plant.
Patent NZ-572768-A (NZ)
Title: Apparatus for access control and processing
Inventor: SAMOVAR KERRY
IPC: G07C9/00
Filed: 2007-05-04
Abstract: A method of controlling access using a computer-based access control system is disclosed. The access control system (122A) receives a request from a user for a plurality of access permits from a user terminal (112A, 114A) over a network (118A). The access control system provides a request that the user provide identification information for the intended recipients of the access permits over the network to the user terminal. The user is informed that one of the access permits needs to be allocated to the user. At least partly in response to receiving the requested identification for the intended recipients, the respective access permits are provided with corresponding unique identifiers related to the respective intended recipients. The unique identifiers are machine readable and/or human readable.
Patent NZ-575514-A (NZ)
Title: Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
Inventor: MCKERRECHER DARREN
IPC: C07D401/14
Filed: 2006-07-03
Abstract: Disclosed is a compound of Formula (I) or a salt thereof wherein the substituents are disclosed within the specification. Also disclosed is the use of the above compound or a pharmaceutically-acceptable slat thereof in the preparation of a medicament for treatment of a disease mediated through GLK such as type 2 diabetes. (62) Divided Out of 564608
Patent NZ-582669-A (NZ)
Title: Hydrolysable polymeric FMOC-linker
Inventor: TURECEK PETER
IPC: A61K47/48
Filed: 2008-06-25
Abstract: Disclosed is a fluorenylmethyloxycarbonyl derivative of formula 1, where Z is a leaving group, at least one of position 1 to 8 is bound to a carbohydrate which is bound to a N-succinimidyl moiety, at least one of an available position 1 to 8 is optionally bound to -SO3-R3, and wherein the remainder of the substituents are as defined in the specification. Also disclosed is a process for the preparation of the compound. Also disclosed are blood coagulation factors bound to the compound.
Patent NZ-584475-A (NZ)
Title: Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
Inventor: JOSHI PRAMOD
IPC: C07D285/12
Filed: 2008-10-10
Abstract: The disclosure relates to heteroaryl amide compounds of formula (I'') which are useful as inhibitors of voltage-gated sodium channels, wherein the variables shown in formula (I'') are as defined in the specification. The disclosure also relates to pharmaceutically acceptable compositions comprising these compounds and their use for treating or lessening the severity in a subject of one or more of acute, chronic, neuropathic, or inflammatory pain, arthritis, migraine, cluster headaches, trigeminal neuralgia, herpetic neuralgia, general neuralgias, epilepsy or epilepsy conditions, neurodegenerative disorders, psychiatric disorders such as anxiety and depression, dipolar disorder, myotonia, arrhythmia, movement disorders, neuroendocrine disorders, ataxia, multiple sclerosis, irritable bowel syndrome, incontinence, visceral pain, osteoarthritis pain, postherpetic neuralgia, diabetic neuropathy, radicular pain, sciatica, back pain, head or neck pain, severe or intractable pain, nociceptive pain, breakthrough pain, postsurgical pain, cancer pain, stroke, cerebral ischemia, traumatic brain injury, amyotrophic lateral sclerosis, stress- or exercise induced angina, palpitations, hypertension, migraine, or abnormal gastro-intestinal motility the compositions in the treatment of various disorders.
Patent NZ-588814-A (NZ)
Title: Method of insect control using stepped frequency sweeps to resonate with the structure of an insects wing
Inventor: CAO JINAN
IPC: A01K29/00
Filed: 2010-10-27
Abstract: A method of insect control by broadcasting frequency sweeping sound waves to cause malfunction of the wing beating system of flying insects is disclosed. The method comprises of determining the frequency range of the wing (2) beats of insects (1) then generating a series of single frequency sound waves covering all the frequency range of the insects wing beats. Single frequency sound waves being low frequency to high frequency are linked to form ascending, descending and random ordered sound series. The sound series are further linked together to form frequency sweeping sound tracks which can be recorded digitally. Broadcasting (Fig. 2) the sound tracks such that the SPL (sound pressure level) of the sound waves reaches a value higher than 2.0 Pa (i.e. 100 dB) is further disclosed.
Patent NZ-590730-A (NZ)
Title: Stable injectable oil-in-water docetaxel nanoemulsion
Inventor: DAFTARY GAUTAM VINOD
IPC: A61K9/107
Filed: 2009-07-22
Abstract: Disclosed herein is a stable at 25°C, injectable oil-in-water Docetaxel nanoemulsion composition having droplet size 20-200nm and pH 4.0-5.5, devoid of hypersensitivity reaction and fluid retention, giving higher plasma concentrations of Docetaxel and enhanced permeability retention effect, when injected comprising Docetaxel; Synthetic triglyceride oil as the only oil component; N-(carbonyl-methoxypolyethylene glycol)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine in which the PEG chain has a molecular weight of 2000 to 5000 and Purified natural phosphatide as the only emulsifiers; glycerol; and Water for injection and free from any further solvent or co-solvent. Also discloses is a lyophilised composition for parenteral administration from the above stable nanoemulsion as well as processes for their preparation
Patent NZ-593743-A (NZ)
Title: Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms
Inventor: FROST PHILLIP
IPC: C07H21/00
Filed: 2009-12-04
Abstract: Disclosed herein are siRNA compositions and methods useful for inhibiting expression of vascular endothelial growth factor (VEGF) isoforms. Such compositions and methods further involve siRNA capable of selectively targeting angiogenic VEGF isoforms while selectively sparing anti-angiogenic isoforms. Diseases which involve angiogenesis stimulated by overexpression of VEGF, such as diabetic retinopathy, age related macular degeneration and many types of cancer, can be treated by administering small interfering RNAs as disclosed.
Patent NZ-599442-A (NZ)
Title: Allergy treatment using acid treated aqueous whey protein extract
Inventor: PENTTILA IRMELI AULI
IPC: A23L33/00
Filed: 2010-10-14
Abstract: Disclosed is a process for the production of a whey protein extract from a whey protein concentrate including: - contacting a whey protein-containing composition with an aqueous solution, thereby forming a sample including a soluble protein-containing component and an insoluble component; - recovering the soluble protein-containing component from the sample; - acidifying the soluble protein-containing component; - neutralizing the acidified soluble protein-containing component; thereby forming the whey protein extract.
Patent NZ-601857-A (NZ)
Title: Brachytherapy template adaptor
Inventor: HELLE KEVIN
IPC: A61N5/00
Filed: 2011-03-31
Abstract: A brachytherapy template and a brachytherapy template adaptor for the brachytherapy template. The brachytherapy template (2) comprises a plurality of through-passages, and the brachytherapy template adaptor (10) comprises a brachytherapy template adaptor body defining a plurality of adaptor through-passages (22) arrayed to be positioned in unique fluid registry with the plurality of through-passages of the brachytherapy template. At least a portion of the adaptor through-passages comprises a cylindrical surface have a smaller transverse span than the through-passages of the brachytherapy template. A kit comprising a brachytherapy template, an adaptor and a plurality of guide pins (30) is also provided. The guide pins are adapted to hold the template adaptor to the template so that each through passageway of the template adaptor extends in fluid communication with a through passageway of the template.
Patent NZ-614617-A (NZ)
Title: Multistage comminuting pump
Inventor: UBELS WARREN EDWIN
IPC: F04D29/44
Filed: 2012-06-06
Abstract: A multi-stage comminuting pump used for example with agricultural effluents arising from a cowshed or feedlot pad is capable of developing an output pressure up to 100 to 140 metres water while breaking up, or shredding, any suspended fibrous solids such as straw. In each stage, the vanes (115, 119) of a non-rotating diffuser (116, 120) are located in close proximity to a turning disk comprising the rear of a previous impeller stage and having slots for comminution of suspended solids. The impeller (114, 118) of each stage turns close to a fixed plate also carrying comminuting slots. A venturi-assisted suction stage option is described.
Patent NZ-624636-A (NZ)
Title: Novel compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations
Inventor: KARMALI RASHIDA A
IPC: A01N43/82
Filed: 2013-02-27
Abstract: Disclosed are polymorph forms of 5-amino-1-(4-(4-chlorobenzoyl)-3 ,5-dichlorobenzyl)-1 ,2,3 triazole-4-carboxamide defined by powder x-ray diffraction patterns (XRPD).
Patent NZ-624989-A (NZ)
Title: Antigen binding protein and its use as addressing product for the treatment cancer
Inventor: BEAU-LARVOR CHARLOTTE
IPC: C07K16/28
Filed: 2012-11-05
Abstract: Disclosed is an antigen binding protein, or an antigen binding fragment thereof, which: i) specifically binds to the human protein Axl, and ii) is internalised following its binding to the human protein Axl, the antigen binding protein comprising the CDRs according to KSISKY, SGS, QQHHEYPLT, GFNIRDTY, LDPANGHT and ARGAYYYGSSGLFYFDY. Also disclosed is its use in treating cancer.
Patent NZ-630582-A (NZ)
Title: Conjugate of a photosensitiser and chitosan and uses thereof
Inventor: BERG KRISTIAN
IPC: A61P35/00
Filed: 2013-05-14
Abstract: Disclosed are novel chitosan-based conjugates, e.g. nanocarriers, comprising a derivative of the biocompatible polymer chitosan conjugated to a photosensitising agent, and uses thereof in photochemical internalisation (PCI) and photodynamic therapy (PDT). The invention also relates to the use of the novel conjugates of the invention in treatment or prevention of diseases, particularly cancer, and for vaccination purposes.
Patent NZ-630803-A (NZ)
Title: Optically active pde10 inhibitor
Inventor: ZUTA CHARLES PRINCE
IPC: C07D307/46
Filed: 2014-09-10
Abstract: Disclosed herein is (S)-1-(5-(4-chloro-3,5-dimethoxyphenyl)furan-2-yl)-2-ethoxy-2-(4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl)ethanone. Also disclosed are crystal forms of (S)-1-(5-(4-chloro-3,5-dimethoxyphenyl)furan-2-yl)-2-ethoxy-2-(4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl)ethanone, pharmaceutical compositiona of the compound, processes for its synthesis and the use of the compound for inhibiting PDE10 and treatment of neurological disorders such as schizophrenia and post-traumatic stress disorder.
Patent NZ-630890-A (NZ)
Title: Microrna compounds and methods for modulating mir-122
Inventor: HOGAN DANIEL
IPC: C12N15/113
Filed: 2014-04-30
Abstract: Disclosed is a compound comprising a modified oligonucleotide consisting of 16 to 22 linked nucleosides, wherein the nucleobase sequence of the modified oligonucleotide is at least 90% complementary to miR-122 (SEQ ID NO: 1) and wherein the modified oligonucleotide comprises at least 16 contiguous nucleosides of the following nucleoside pattern I the 5’ to 3’ orientation: (R)X-NQ-NQ-NB-NB-NQ-NB-NQ-NB-NQ-NB-NB-(NZ)Y wherein each R is, independently, a non-bicyclic nucleoside or a bicyclic nucleoside; X is from 4 to 10; each NB is, independently, a bicyclic nucleoside; each NQ is, independently, a non-bicyclic nucleoside; Y is 0 or 1; and NZ is a modified nucleoside or an unmodified nucleoside.
Patent NZ-731789-A (NZ)
Title: Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof
Inventor: GE CHUANSHENG
IPC: A61K31/5375
Filed: 2015-08-27
Abstract: Provided are an isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof. The isoindoline derivative and the pharmaceutical composition thereof can regulate the production or activity of immunological cytokines, thus effectively treating cancer and inflammatory disease.
Patent NZ-733383-A (NZ)
Title: Oil-based adjuvants
Inventor: DOMINOWSKI PAUL
IPC: A61K9/107
Filed: 2014-09-19
Abstract: The instant invention provides various formulations comprising combinations of immunostimulating oligonucleotides, polycationic carriers, sterols, saponins, quaternary amines, TLR-3 agonists, glycolipids, and MPL-A or analogs thereof in oil emulsions, use thereof in preparations of immunogenic compositions and vaccines, and use thereof in the treatment of animals. In a specific embodiment the invention is an immunogenic composition comprising an effective amount of a Foot-and-Mouth Disease Virus (FMDV) antigen and an adjuvant formulation comprising an oily phase in the amount of at least 36% v/v and an aqueous phase, a polycationic carrier, and a CpG containing immunostimulatory oligonucleotide, wherein the immunogenic composition is a water-in-oil emulsion, wherein the polycationic carrier is DEAE dextran, wherein the CpG containing immunostimulatory oligonucleotide is a P-class CpG immunostimulatory oligonucleotide containing a 5’ TLR activation domain and at least two palindromic regions, one palindromic region being a 5’ palindromic region of at least 6 nucleotides in length and connected to a 3’ palindromic region of at least 8 nucleotides in length either directly or through a spacer and wherein the Foot-and-Mouth Disease Virus (FMDV) antigen is an inactivated or modified live FMD virus.
Patent NZ-736020-A (NZ)
Title: Apparatus and method for processing meat
Inventor: ROBERTS COLIN ANDREW
IPC: A22C17/02
Filed: 2011-03-15
Abstract: Disclosed is a chine removal apparatus for meat animal carcasses. The apparatus includes a guide defining a centreline, and an upper blade positioned substantially in line with the centreline, and having a downwards facing cutting surface. At least one lifting arm biased in an upwards direction to press an animal rack being processed by the apparatus against the upper blade; and a lower blade or saw having an upwards facing edge and configured to act against the rack in conjunction with the upper blade to sever the rack. the at least one lifting arm includes a first lifting arm and a second lifting arm positioned sequentially along a side of the guide, the second lifting arm is configured to project higher than the first lifting arm. A pressure arm is configured to act upwardly on a portion of the rack laterally disposed from the guide such that the ribs are spread away from the centreline. The apparatus controls the extent to which pressure is applied by the pressure arm in accordance with predetermined settings associated with a particular product specification.
Patent NZ-741595-A (NZ)
Title: Prefabricated fence
Inventor: BARRY HODGE
IPC: E04H17/02
Filed: 2018-04-12
Abstract: A prefabricated wire fence (10) of the type that comprises longitudinal strands (15) and regularly spaced transverse pickets (14). The prefabricated wire fence (10) comprises one or more reinforced regions (20) comprising a plurality of transverse pickets (14) inset from an end of the prefabricated wire fence (10). When the fence is installed, a reinforced region (20) may locate adjacent to anchor/end posts in a fence line and may help to absorb, accommodate, resist, etc. possible excess/large forces, stresses and/or strain should it become a convergence point for cattle against the fence line.
Patent NZ-744244-A (NZ)
Title: Patient interface and method for making same
Inventor: BARLOW ADAM
IPC: F16L11/00
Filed: 2014-01-16
Abstract: A patient interface to provide breathable gas to a patient, the patient interface comprising: a seal-forming structure and a plenum chamber formed in one piece, the seal-forming structure being constructed and arranged to form a seal against the patient’s face surrounding both nares and without entering the nares, the seal-forming structure being configured to seal around an inferior periphery of the patient’s nose and below the bridge of the nose, and the plenum chamber including a plenum connection region; and a frame comprising a frame connection region and a headgear connection region; wherein the frame connection region is configured for attachment to the plenum chamber at the plenum connection region, and wherein the plenum connection region of the plenum chamber further comprises a sealing lip that is adapted to form a pneumatic seal between the plenum connection region and the frame connection region. The configuration of the seal forming structure reduces interference with bridge of wearer’s nose and eye-glasses.
Patent NZ-748106-A (NZ)
Title: Mechanical snow and ice removal for impinger
Inventor: BOYLES SCOTT
IPC: F25D21/06
Filed: 2017-07-18
Abstract: An impingement apparatus associated with a conveyor includes: (a) a shell supporting an impinger; and (b) a coolant delivery apparatus enclosed by the shell, the coolant delivery apparatus including a gas circulation device for directing a coolant to the impinger; the impinger including: (i) an impingement plate including openings for directing impingement jets toward the conveyor; (ii) at least one non-circular cam in mechanical communication with the at least one conveyor and rotatable when the conveyor is in motion; and (iii) at least one connector in mechanical communication with the at least one cam and the impingement plate, the connector displaceable during rotation of the at least one cam to elevate and lower the impingement plate. The action of elevating and lowering the impingement plate creates a hammer effect, which vibrates the plate to break up built-up snow and ice, which falls through the openings in the plate.
Patent OA-12190-A (OA)
Title: Synergistic herbicidal agents based on leaf herbicides containing phosphorus, imidazolinones and hormone weed-killers.
Inventor: KUAH TAI CHOON
IPC: A01N57/20
Filed: 1999-03-30
Abstract: Herbicidal agents containing a combination  (A)+(B)+(C) of (A) leaf-effective herbicides from the group of glufosinates and the esters and salts thereof, glufosinate peptides, such as bialaphos, and the salts thereof, glyphosates and the salts thereof, e.g. also sulfosates, (B) imidazolinone herbicides and the salts thereof and (C) one or more active substances from the group of hormone weed-killers and the salts thereof. Said herbicidal agents have synergistic herbicidal effects.
Patent PT-105840-A (PT)
Title: Ferrovia de estrutura melhorada
Inventor: SANTOS SILVINO POMPEU
IPC: E01B1/00
Filed: 2011-07-28
Abstract: A FERROVIA DE ESTRUTURA MELHORADA É UMA FERROVIA COM UMA ESTRUTURA CONSTITUÍDA POR UM TAPETE DE BETÃO BETUMINOSO (4) ASSENTE SOBRE UMA CAMADA DE FORMA (2), SOBRE O QUAL É INSTALADA UMA LAJE (5) EM BETÃO, A QUAL É PROVIDA DE NERVURAS LONGITUDINAIS NA FACE SUPERIOR E É REFORÇADA COM ARMADURAS LONGITUDINAIS E TRANSVERSAIS EM AÇO. AS NERVURAS LONGITUDINAIS DA LAJE (5) SÃO DISPOSTAS NA ZONA DOS BORDOS LATERAIS E NA ZONA CENTRAL ENTRE CARRIS, OU APENAS NUMA DESTAS ZONAS.